271 related articles for article (PubMed ID: 19236546)
1. The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study: Shanghai Combizym Clinical Cooperative Group.
Ran ZH; Yuan YZ; Li ZS; Wang JY; Zong CH; Xie WF; Zheng P; Chen SL; Zhan XB; Chen SY; Xiao SD
J Dig Dis; 2009 Feb; 10(1):41-8. PubMed ID: 19236546
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of postprandial discomfort syndrome in the elderly: a multi-centered prospective randomized controlled clinical study].
Wang GS; Xu L; Chen HT; Shi LP; Huang MJ; Xi L; Xu LS; Wang F; Li HY; Li S; Zhang YJ; Tan SY; Hong RT; Lyu NH; Ye M; Gan HT; Liu M; Wu BY;
Zhonghua Nei Ke Za Zhi; 2020 Feb; 59(2):117-123. PubMed ID: 32074684
[No Abstract] [Full Text] [Related]
3. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
[TBL] [Abstract][Full Text] [Related]
4. [A randomized controlled Multi-center clinical trial on mosapride in the treatment of functional dyspepsia].
Chen SY; Wang JY; Zhu CW; Yuan YZ; Zou B; Xia L; Liu JY; Xu HW; Zhang SZ; Wang Q; Xie XJ; Zhao ZQ; Lin L; Hu NZ; Xu JM
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Feb; 25(2):165-8. PubMed ID: 15132875
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
6. Tegaserod in patients with mechanical sensitivity and overlapping symptoms of functional heartburn and functional dyspepsia.
Miner PB; Rodriguez-Stanley S; Proskin HM; Kianifard F; Bottoli I
Curr Med Res Opin; 2008 Aug; 24(8):2159-72. PubMed ID: 18561877
[TBL] [Abstract][Full Text] [Related]
7. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study].
Madisch A; Melderis H; Mayr G; Sassin I; Hotz J
Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the 5-HT1A agonist tandospirone citrate in improving symptoms of patients with functional dyspepsia: a randomized controlled trial.
Miwa H; Nagahara A; Tominaga K; Yokoyama T; Sawada Y; Inoue K; Ashida K; Fukuchi T; Hojo M; Yamashita H; Tomita T; Hori K; Oshima T
Am J Gastroenterol; 2009 Nov; 104(11):2779-87. PubMed ID: 19638966
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled crossover trial of famotidine in patients with functional dyspepsia.
Kato M; Watanabe M; Konishi S; Kudo M; Konno J; Meguro T; Kitamori S; Nakagawa S; Shimizu Y; Takeda H; Asaka M
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():27-31. PubMed ID: 15943843
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study.
Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T
Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083
[TBL] [Abstract][Full Text] [Related]
12. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
[TBL] [Abstract][Full Text] [Related]
13. A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia.
Tack J; Van Den Elzen B; Tytgat G; Wajs E; Van Nueten L; De Ridder F; Boeckxstaens G
Neurogastroenterol Motil; 2009 Jun; 21(6):619-26, e23-4. PubMed ID: 19220756
[TBL] [Abstract][Full Text] [Related]
14. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.
Tack J; Janssen P; Masaoka T; Farré R; Van Oudenhove L
Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1239-45. PubMed ID: 22813445
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia.
May B; Kuntz HD; Kieser M; Köhler S
Arzneimittelforschung; 1996 Dec; 46(12):1149-53. PubMed ID: 9006790
[TBL] [Abstract][Full Text] [Related]
17. Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses.
Mearin F; Balboa A; Zárate N; Cucala M; Malagelada JR
Am J Gastroenterol; 1999 Jan; 94(1):116-25. PubMed ID: 9934741
[TBL] [Abstract][Full Text] [Related]
18. Predictors of the placebo response in functional dyspepsia.
Talley NJ; Locke GR; Lahr BD; Zinsmeister AR; Cohard-Radice M; D'Elia TV; Tack J; Earnest DL
Aliment Pharmacol Ther; 2006 Apr; 23(7):923-36. PubMed ID: 16573795
[TBL] [Abstract][Full Text] [Related]
19. [Ranitidine therapeutically effective in functional dyspepsia with reflux-like symptoms].
Jebbink HJ; Smout AJ; van Berge Henegouwen GP
Ned Tijdschr Geneeskd; 1993 Aug; 137(35):1772-5. PubMed ID: 8371822
[TBL] [Abstract][Full Text] [Related]
20. Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials.
Vakil N; Laine L; Talley NJ; Zakko SF; Tack J; Chey WD; Kralstein J; Earnest DL; Ligozio G; Cohard-Radice M
Am J Gastroenterol; 2008 Aug; 103(8):1906-19. PubMed ID: 18616658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
